 Tunuguntla Kumar
Concepts (432)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Follicle Stimulating Hormone | 34 | 2024 | 249 | 5.840 |
Why?
| | Follicle Stimulating Hormone, beta Subunit | 23 | 2023 | 31 | 3.860 |
Why?
| | Testis | 15 | 2025 | 163 | 2.250 |
Why?
| | Luteinizing Hormone | 13 | 2022 | 190 | 1.980 |
Why?
| | Sertoli Cells | 10 | 2025 | 28 | 1.690 |
Why?
| | Spermatogenesis | 6 | 2025 | 91 | 1.620 |
Why?
| | Reproduction | 10 | 2019 | 207 | 1.560 |
Why?
| | Mice, Knockout | 38 | 2025 | 3121 | 1.510 |
Why?
| | Gonadotrophs | 3 | 2015 | 21 | 1.320 |
Why?
| | Integrases | 2 | 2025 | 122 | 1.260 |
Why?
| | Ovary | 17 | 2018 | 228 | 1.250 |
Why?
| | Pituitary Gland | 8 | 2020 | 148 | 1.180 |
Why?
| | Mice, Transgenic | 27 | 2025 | 2182 | 1.150 |
Why?
| | Mice | 79 | 2025 | 18339 | 1.010 |
Why?
| | Animals | 89 | 2025 | 38058 | 0.960 |
Why?
| | Follicle Stimulating Hormone, Human | 3 | 2023 | 12 | 0.930 |
Why?
| | Androgens | 5 | 2022 | 186 | 0.900 |
Why?
| | Ribonuclease III | 2 | 2015 | 44 | 0.890 |
Why?
| | DEAD-box RNA Helicases | 2 | 2015 | 90 | 0.850 |
Why?
| | Gene Knockout Techniques | 1 | 2025 | 116 | 0.850 |
Why?
| | Gonadotropins | 5 | 2022 | 39 | 0.840 |
Why?
| | Fertility | 8 | 2015 | 168 | 0.820 |
Why?
| | Receptors, FSH | 6 | 2018 | 9 | 0.740 |
Why?
| | Amino Acid Transport System y+ | 1 | 2022 | 9 | 0.730 |
Why?
| | Biology | 2 | 2019 | 91 | 0.670 |
Why?
| | Inhibins | 13 | 2008 | 41 | 0.650 |
Why?
| | Protein Processing, Post-Translational | 3 | 2019 | 477 | 0.620 |
Why?
| | Signal Transduction | 13 | 2018 | 5226 | 0.600 |
Why?
| | Leydig Cells | 6 | 2025 | 15 | 0.590 |
Why?
| | Laboratory Personnel | 1 | 2019 | 4 | 0.590 |
Why?
| | Genetics | 1 | 2019 | 23 | 0.570 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 5 | 2023 | 23 | 0.550 |
Why?
| | Luteinizing Hormone, beta Subunit | 3 | 2007 | 4 | 0.540 |
Why?
| | Oogenesis | 1 | 2017 | 19 | 0.520 |
Why?
| | Ovarian Follicle | 8 | 2019 | 73 | 0.500 |
Why?
| | Gene Expression Regulation | 11 | 2019 | 2608 | 0.480 |
Why?
| | Activin Receptors, Type II | 3 | 2005 | 12 | 0.480 |
Why?
| | Infertility | 3 | 2005 | 55 | 0.480 |
Why?
| | Recombinant Proteins | 4 | 2016 | 1370 | 0.480 |
Why?
| | Glycosylation | 4 | 2023 | 172 | 0.460 |
Why?
| | Models, Genetic | 1 | 2018 | 536 | 0.440 |
Why?
| | PAX7 Transcription Factor | 1 | 2014 | 13 | 0.430 |
Why?
| | RNA, Messenger | 14 | 2023 | 2832 | 0.410 |
Why?
| | Female | 54 | 2024 | 78271 | 0.410 |
Why?
| | Epididymis | 2 | 2012 | 14 | 0.400 |
Why?
| | Male | 49 | 2025 | 72315 | 0.400 |
Why?
| | Gonadotropin-Releasing Hormone | 6 | 2022 | 212 | 0.400 |
Why?
| | Spermatozoa | 2 | 2010 | 109 | 0.380 |
Why?
| | Gene Expression | 10 | 2020 | 1490 | 0.380 |
Why?
| | Steroids | 4 | 2018 | 160 | 0.380 |
Why?
| | Glycoproteins | 7 | 2004 | 355 | 0.370 |
Why?
| | Infertility, Female | 6 | 2003 | 112 | 0.370 |
Why?
| | Cyclin D3 | 1 | 2012 | 4 | 0.360 |
Why?
| | Granulosa Cells | 4 | 2019 | 33 | 0.360 |
Why?
| | Cyclin D2 | 1 | 2012 | 5 | 0.360 |
Why?
| | Infertility, Male | 4 | 2001 | 73 | 0.360 |
Why?
| | Cyclin D1 | 1 | 2012 | 61 | 0.350 |
Why?
| | Hypogonadism | 4 | 2014 | 90 | 0.350 |
Why?
| | Inhibin-beta Subunits | 3 | 2007 | 6 | 0.350 |
Why?
| | Chorionic Gonadotropin | 4 | 2007 | 77 | 0.340 |
Why?
| | Real-Time Polymerase Chain Reaction | 4 | 2016 | 341 | 0.340 |
Why?
| | Testosterone | 8 | 2022 | 419 | 0.330 |
Why?
| | Stem Cells | 3 | 2014 | 626 | 0.330 |
Why?
| | Molecular Imaging | 1 | 2010 | 55 | 0.320 |
Why?
| | Models, Animal | 3 | 2006 | 392 | 0.320 |
Why?
| | History, 20th Century | 3 | 2019 | 325 | 0.320 |
Why?
| | Plasmodium berghei | 4 | 2016 | 7 | 0.310 |
Why?
| | Biological Evolution | 1 | 2014 | 488 | 0.310 |
Why?
| | Embryonic Development | 1 | 2010 | 125 | 0.300 |
Why?
| | Oocytes | 3 | 2018 | 178 | 0.300 |
Why?
| | Anti-Mullerian Hormone | 4 | 2019 | 57 | 0.300 |
Why?
| | Aging | 4 | 2018 | 1966 | 0.290 |
Why?
| | Gonadotropins, Pituitary | 2 | 2005 | 22 | 0.290 |
Why?
| | Disease Models, Animal | 6 | 2012 | 4557 | 0.290 |
Why?
| | Osteoporosis | 3 | 2017 | 236 | 0.280 |
Why?
| | Pituitary Gland, Anterior | 4 | 1998 | 37 | 0.270 |
Why?
| | History, 21st Century | 2 | 2019 | 219 | 0.270 |
Why?
| | Ovulation | 3 | 2014 | 41 | 0.240 |
Why?
| | Receptors, Gonadotropin | 1 | 2005 | 1 | 0.230 |
Why?
| | Testicular Neoplasms | 3 | 2008 | 113 | 0.230 |
Why?
| | Antimalarials | 3 | 2016 | 35 | 0.230 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2006 | 381 | 0.220 |
Why?
| | Transgenes | 4 | 2016 | 189 | 0.220 |
Why?
| | Sexual Behavior, Animal | 1 | 2005 | 57 | 0.220 |
Why?
| | Humans | 30 | 2024 | 144759 | 0.220 |
Why?
| | Base Sequence | 9 | 2018 | 2190 | 0.220 |
Why?
| | Mutation | 9 | 2008 | 4089 | 0.210 |
Why?
| | MicroRNAs | 3 | 2017 | 701 | 0.210 |
Why?
| | Receptors, LHRH | 1 | 2003 | 14 | 0.210 |
Why?
| | Hormones | 1 | 2004 | 134 | 0.200 |
Why?
| | Receptors, Growth Factor | 2 | 2001 | 56 | 0.200 |
Why?
| | Cysteine | 2 | 2022 | 210 | 0.200 |
Why?
| | Freeze Drying | 1 | 2004 | 82 | 0.200 |
Why?
| | Ovarian Neoplasms | 4 | 2008 | 586 | 0.200 |
Why?
| | Mice, Inbred C57BL | 16 | 2013 | 5992 | 0.190 |
Why?
| | Blotting, Western | 2 | 2016 | 1187 | 0.190 |
Why?
| | Adiposity | 2 | 2018 | 543 | 0.190 |
Why?
| | Liver | 4 | 2018 | 1887 | 0.190 |
Why?
| | Cystine | 1 | 2022 | 18 | 0.180 |
Why?
| | Pharmaceutical Preparations | 1 | 2004 | 170 | 0.180 |
Why?
| | Activins | 9 | 2020 | 29 | 0.180 |
Why?
| | Glutamates | 1 | 2022 | 66 | 0.180 |
Why?
| | Models, Biological | 4 | 2018 | 1821 | 0.180 |
Why?
| | Genes, Dominant | 2 | 2013 | 101 | 0.170 |
Why?
| | Homeostasis | 2 | 2022 | 640 | 0.170 |
Why?
| | Mice, Mutant Strains | 7 | 2013 | 299 | 0.170 |
Why?
| | gamma-Glutamyltransferase | 1 | 2000 | 42 | 0.160 |
Why?
| | Sequence Analysis, RNA | 1 | 2023 | 442 | 0.160 |
Why?
| | Forkhead Box Protein L2 | 1 | 2020 | 3 | 0.160 |
Why?
| | Smad4 Protein | 1 | 2020 | 34 | 0.160 |
Why?
| | Glutathione | 1 | 2022 | 375 | 0.160 |
Why?
| | Promoter Regions, Genetic | 4 | 2018 | 1257 | 0.160 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2019 | 125 | 0.160 |
Why?
| | Biocompatible Materials | 1 | 2004 | 435 | 0.150 |
Why?
| | Receptors, Androgen | 3 | 2006 | 153 | 0.150 |
Why?
| | Genes, Lethal | 1 | 1999 | 30 | 0.150 |
Why?
| | Bone Morphogenetic Protein 15 | 2 | 2018 | 2 | 0.150 |
Why?
| | Growth Differentiation Factor 9 | 2 | 2018 | 4 | 0.150 |
Why?
| | Phenotype | 7 | 2007 | 3162 | 0.150 |
Why?
| | Oxidants | 1 | 1999 | 103 | 0.150 |
Why?
| | Genes, Tumor Suppressor | 2 | 1998 | 83 | 0.150 |
Why?
| | Spiro Compounds | 1 | 2018 | 17 | 0.140 |
Why?
| | Receptors, Steroid | 1 | 2019 | 45 | 0.140 |
Why?
| | Bone and Bones | 3 | 2013 | 314 | 0.140 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 1998 | 15 | 0.140 |
Why?
| | Oligospermia | 2 | 2013 | 13 | 0.140 |
Why?
| | Neoplasms, Experimental | 2 | 1998 | 173 | 0.140 |
Why?
| | Esters | 1 | 2018 | 78 | 0.140 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2018 | 8 | 0.140 |
Why?
| | Benzene Derivatives | 2 | 2012 | 10 | 0.130 |
Why?
| | Texas | 1 | 2019 | 278 | 0.130 |
Why?
| | Placentation | 1 | 2018 | 53 | 0.130 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 140 | 0.130 |
Why?
| | Bone Development | 1 | 2018 | 52 | 0.130 |
Why?
| | Oligopeptides | 1 | 1999 | 269 | 0.130 |
Why?
| | Phosphorylation | 3 | 2019 | 1732 | 0.130 |
Why?
| | Thermogenesis | 1 | 2017 | 45 | 0.130 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 185 | 0.130 |
Why?
| | Gonads | 3 | 2007 | 23 | 0.130 |
Why?
| | Genital Neoplasms, Male | 1 | 1996 | 4 | 0.130 |
Why?
| | Gene Targeting | 3 | 2007 | 82 | 0.130 |
Why?
| | Aromatase | 3 | 2006 | 32 | 0.120 |
Why?
| | Meiosis | 1 | 2017 | 101 | 0.120 |
Why?
| | Time Factors | 4 | 2016 | 7173 | 0.120 |
Why?
| | Pituitary Neoplasms | 1 | 1998 | 190 | 0.120 |
Why?
| | Growth Substances | 4 | 1998 | 140 | 0.120 |
Why?
| | Microtubule-Associated Proteins | 1 | 2017 | 196 | 0.120 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2016 | 20 | 0.120 |
Why?
| | Osteoclasts | 2 | 2006 | 52 | 0.120 |
Why?
| | Cattle | 2 | 2015 | 1000 | 0.120 |
Why?
| | Adenoma | 1 | 1998 | 218 | 0.120 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 219 | 0.120 |
Why?
| | Phagocytosis | 1 | 2017 | 299 | 0.120 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 145 | 0.120 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 259 | 0.110 |
Why?
| | Genital Neoplasms, Female | 1 | 1996 | 99 | 0.110 |
Why?
| | Autophagy | 1 | 2017 | 286 | 0.110 |
Why?
| | Wasting Syndrome | 3 | 2000 | 12 | 0.110 |
Why?
| | Cell Cycle | 3 | 2018 | 596 | 0.110 |
Why?
| | Metallothionein | 4 | 2003 | 25 | 0.110 |
Why?
| | Microscopy, Immunoelectron | 1 | 2014 | 43 | 0.100 |
Why?
| | Molecular Sequence Data | 4 | 2006 | 2930 | 0.100 |
Why?
| | Superovulation | 3 | 2006 | 8 | 0.100 |
Why?
| | Pituitary Hormones | 1 | 2013 | 15 | 0.100 |
Why?
| | Triclosan | 2 | 2011 | 9 | 0.100 |
Why?
| | Uterus | 3 | 2004 | 226 | 0.100 |
Why?
| | Osteocalcin | 1 | 2013 | 38 | 0.100 |
Why?
| | Dihydrotestosterone | 1 | 1993 | 42 | 0.100 |
Why?
| | Thioctic Acid | 1 | 2013 | 12 | 0.100 |
Why?
| | Bone Resorption | 3 | 2013 | 80 | 0.100 |
Why?
| | Microscopy, Confocal | 1 | 2014 | 321 | 0.100 |
Why?
| | Apoptosis | 2 | 2017 | 2430 | 0.100 |
Why?
| | Malaria | 2 | 2011 | 73 | 0.090 |
Why?
| | Organ Specificity | 3 | 2012 | 312 | 0.090 |
Why?
| | Malaria, Falciparum | 1 | 2012 | 33 | 0.090 |
Why?
| | Adipose Tissue | 1 | 2017 | 652 | 0.090 |
Why?
| | Testicular Hormones | 2 | 2003 | 8 | 0.090 |
Why?
| | Urea | 1 | 2012 | 84 | 0.090 |
Why?
| | Protozoan Proteins | 2 | 2013 | 93 | 0.090 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2017 | 157 | 0.090 |
Why?
| | Pregnancy | 4 | 2018 | 7190 | 0.090 |
Why?
| | Rats | 4 | 2014 | 5597 | 0.090 |
Why?
| | Host-Parasite Interactions | 1 | 2013 | 112 | 0.090 |
Why?
| | Estradiol | 2 | 2008 | 533 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 710 | 0.090 |
Why?
| | Castration | 2 | 2003 | 15 | 0.090 |
Why?
| | Ki-67 Antigen | 1 | 2012 | 117 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2014 | 1306 | 0.080 |
Why?
| | Sex Factors | 3 | 2006 | 2112 | 0.080 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 233 | 0.080 |
Why?
| | Epithelium | 1 | 2012 | 314 | 0.080 |
Why?
| | Anti-Infective Agents, Local | 1 | 2011 | 40 | 0.080 |
Why?
| | Pancreas | 1 | 2013 | 341 | 0.080 |
Why?
| | Osteoblasts | 2 | 2013 | 145 | 0.080 |
Why?
| | Sperm Motility | 1 | 2010 | 35 | 0.080 |
Why?
| | Amino Acid Sequence | 4 | 2013 | 2155 | 0.080 |
Why?
| | Ovariectomy | 3 | 2017 | 162 | 0.080 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 56 | 0.080 |
Why?
| | Seminal Vesicles | 2 | 2000 | 9 | 0.080 |
Why?
| | Radioimmunoassay | 2 | 2004 | 165 | 0.080 |
Why?
| | Embryo, Mammalian | 1 | 2010 | 232 | 0.080 |
Why?
| | Adipocytes | 3 | 2018 | 223 | 0.080 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2006 | 319 | 0.080 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 442 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 269 | 0.070 |
Why?
| | Homozygote | 3 | 1999 | 199 | 0.070 |
Why?
| | Orchiectomy | 3 | 1995 | 74 | 0.070 |
Why?
| | Pseudopregnancy | 1 | 2009 | 4 | 0.070 |
Why?
| | Microinjections | 1 | 2009 | 92 | 0.070 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2008 | 28 | 0.070 |
Why?
| | Polymerase Chain Reaction | 2 | 2009 | 1054 | 0.070 |
Why?
| | Infant | 1 | 2023 | 10034 | 0.070 |
Why?
| | Hyperphagia | 1 | 2008 | 38 | 0.070 |
Why?
| | Plasmodium falciparum | 1 | 2008 | 39 | 0.070 |
Why?
| | Microscopy, Electron | 3 | 2013 | 415 | 0.070 |
Why?
| | Longevity | 2 | 2008 | 173 | 0.070 |
Why?
| | Genes, Reporter | 1 | 2009 | 275 | 0.070 |
Why?
| | Kinetics | 2 | 2018 | 1627 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2194 | 0.060 |
Why?
| | Chorionic Gonadotropin, beta Subunit, Human | 2 | 2006 | 15 | 0.060 |
Why?
| | Ribonucleoproteins, Small Nucleolar | 1 | 2006 | 4 | 0.060 |
Why?
| | Spermatogonia | 1 | 2006 | 15 | 0.060 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 65 | 0.060 |
Why?
| | 3' Flanking Region | 1 | 2006 | 7 | 0.060 |
Why?
| | Cell Line, Tumor | 3 | 2018 | 3540 | 0.060 |
Why?
| | Codon, Terminator | 1 | 2006 | 25 | 0.060 |
Why?
| | Copulation | 1 | 2005 | 5 | 0.060 |
Why?
| | Preoptic Area | 1 | 2005 | 8 | 0.060 |
Why?
| | Penis | 1 | 2005 | 32 | 0.060 |
Why?
| | Genes | 2 | 1995 | 226 | 0.060 |
Why?
| | Olfactory Pathways | 1 | 2005 | 38 | 0.060 |
Why?
| | Cyclic AMP | 2 | 2003 | 209 | 0.060 |
Why?
| | Mice, Inbred ICR | 2 | 2003 | 113 | 0.060 |
Why?
| | Bone Marrow Cells | 1 | 2006 | 320 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 1995 | 540 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2005 | 235 | 0.050 |
Why?
| | Gene Deletion | 4 | 2013 | 389 | 0.050 |
Why?
| | Protein Subunits | 3 | 2014 | 226 | 0.050 |
Why?
| | Genetic Markers | 1 | 2005 | 331 | 0.050 |
Why?
| | CHO Cells | 1 | 2004 | 171 | 0.050 |
Why?
| | Cricetinae | 1 | 2004 | 303 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2012 | 2496 | 0.050 |
Why?
| | Hypothyroidism | 1 | 2004 | 67 | 0.050 |
Why?
| | Thyrotropin | 1 | 2004 | 118 | 0.050 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2006 | 339 | 0.050 |
Why?
| | Biological Assay | 1 | 2004 | 128 | 0.050 |
Why?
| | Reference Values | 1 | 2005 | 797 | 0.050 |
Why?
| | Serum | 1 | 2004 | 58 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 199 | 0.050 |
Why?
| | Peptides | 3 | 2000 | 995 | 0.050 |
Why?
| | Thecoma | 1 | 2003 | 2 | 0.050 |
Why?
| | DNA Damage | 1 | 2006 | 430 | 0.050 |
Why?
| | Fibrin | 1 | 2004 | 91 | 0.050 |
Why?
| | Hypothalamus | 1 | 2003 | 153 | 0.050 |
Why?
| | Dimerization | 1 | 2003 | 194 | 0.050 |
Why?
| | Organ Size | 3 | 2013 | 463 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 983 | 0.050 |
Why?
| | Growth Inhibitors | 1 | 2001 | 39 | 0.040 |
Why?
| | Cells, Cultured | 3 | 2017 | 4154 | 0.040 |
Why?
| | Sperm Count | 1 | 2001 | 20 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1217 | 0.040 |
Why?
| | In Situ Nick-End Labeling | 1 | 2001 | 121 | 0.040 |
Why?
| | Protein Conformation | 1 | 2004 | 946 | 0.040 |
Why?
| | Phylogeny | 1 | 2006 | 1016 | 0.040 |
Why?
| | Protein Binding | 2 | 2018 | 2273 | 0.040 |
Why?
| | Cell Line | 5 | 2017 | 2882 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2018 | 436 | 0.040 |
Why?
| | Wound Healing | 1 | 2004 | 351 | 0.040 |
Why?
| | Motor Activity | 1 | 2005 | 721 | 0.040 |
Why?
| | United States | 1 | 2018 | 15966 | 0.040 |
Why?
| | Growth Hormone | 1 | 2000 | 92 | 0.040 |
Why?
| | Obesity | 2 | 2017 | 3077 | 0.040 |
Why?
| | Sex Characteristics | 2 | 1998 | 790 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2004 | 380 | 0.040 |
Why?
| | Liver Regeneration | 1 | 2000 | 46 | 0.040 |
Why?
| | Growth Disorders | 1 | 2000 | 86 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2013 | 824 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2020 | 83 | 0.040 |
Why?
| | Follistatin | 4 | 2001 | 12 | 0.040 |
Why?
| | Acetylcysteine | 1 | 2000 | 139 | 0.040 |
Why?
| | tert-Butylhydroperoxide | 1 | 1999 | 9 | 0.040 |
Why?
| | Lethal Dose 50 | 1 | 1999 | 15 | 0.040 |
Why?
| | Mutagens | 1 | 1999 | 26 | 0.040 |
Why?
| | Fetal Death | 1 | 1999 | 58 | 0.040 |
Why?
| | Crosses, Genetic | 1 | 1999 | 124 | 0.040 |
Why?
| | Transcription, Genetic | 3 | 2018 | 1496 | 0.040 |
Why?
| | 3T3-L1 Cells | 1 | 2018 | 36 | 0.040 |
Why?
| | Vibrissae | 1 | 1998 | 11 | 0.040 |
Why?
| | Urinary Tract | 1 | 1999 | 48 | 0.040 |
Why?
| | Cell Shape | 1 | 2018 | 57 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2004 | 1716 | 0.040 |
Why?
| | Smad3 Protein | 1 | 2018 | 43 | 0.040 |
Why?
| | Smad2 Protein | 1 | 2018 | 37 | 0.040 |
Why?
| | Curcumin | 1 | 2018 | 25 | 0.040 |
Why?
| | Hydrolysis | 1 | 2018 | 199 | 0.030 |
Why?
| | Embryonic and Fetal Development | 2 | 1995 | 93 | 0.030 |
Why?
| | Fluorescence | 1 | 2018 | 161 | 0.030 |
Why?
| | Histone Code | 1 | 2018 | 38 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2018 | 168 | 0.030 |
Why?
| | Snail Family Transcription Factors | 1 | 2018 | 18 | 0.030 |
Why?
| | Brain Stem | 1 | 1998 | 95 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 1782 | 0.030 |
Why?
| | Acetylation | 1 | 2018 | 252 | 0.030 |
Why?
| | Isoenzymes | 1 | 1998 | 299 | 0.030 |
Why?
| | Adipose Tissue, Beige | 1 | 2017 | 2 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2018 | 1455 | 0.030 |
Why?
| | Uncoupling Protein 1 | 1 | 2017 | 17 | 0.030 |
Why?
| | DNA | 2 | 1995 | 1463 | 0.030 |
Why?
| | Gonadotropins, Equine | 1 | 1997 | 2 | 0.030 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2017 | 64 | 0.030 |
Why?
| | Adipose Tissue, White | 1 | 2017 | 43 | 0.030 |
Why?
| | Haploinsufficiency | 1 | 2017 | 55 | 0.030 |
Why?
| | Cell Death | 1 | 2018 | 383 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 336 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 1998 | 301 | 0.030 |
Why?
| | Polycystic Ovary Syndrome | 1 | 1999 | 180 | 0.030 |
Why?
| | Tritium | 1 | 2016 | 68 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2018 | 380 | 0.030 |
Why?
| | Uridine | 1 | 2016 | 30 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2016 | 91 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 508 | 0.030 |
Why?
| | Genes, Retinoblastoma | 1 | 1995 | 8 | 0.030 |
Why?
| | Growth | 1 | 1996 | 49 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 476 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2017 | 261 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1995 | 85 | 0.030 |
Why?
| | Genes, p53 | 1 | 1995 | 67 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 627 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2018 | 618 | 0.030 |
Why?
| | Blotting, Northern | 1 | 1995 | 204 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2016 | 388 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 688 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1995 | 396 | 0.030 |
Why?
| | Antibodies | 1 | 2017 | 401 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 1996 | 381 | 0.030 |
Why?
| | Cell Differentiation | 4 | 2006 | 2050 | 0.030 |
Why?
| | Introns | 1 | 1995 | 254 | 0.030 |
Why?
| | Exons | 1 | 1995 | 358 | 0.030 |
Why?
| | Adenosine | 1 | 2016 | 255 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2017 | 724 | 0.030 |
Why?
| | Hemorrhage | 1 | 1999 | 809 | 0.030 |
Why?
| | Body Weight | 2 | 2008 | 976 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 86 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1907 | 0.020 |
Why?
| | Immunoblotting | 1 | 1993 | 300 | 0.020 |
Why?
| | Desmocollins | 1 | 2012 | 2 | 0.020 |
Why?
| | DNA Primers | 1 | 2013 | 512 | 0.020 |
Why?
| | Mice, Inbred C3H | 2 | 2006 | 251 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1047 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 304 | 0.020 |
Why?
| | Species Specificity | 1 | 1993 | 574 | 0.020 |
Why?
| | Drug Discovery | 1 | 2012 | 155 | 0.020 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2013 | 198 | 0.020 |
Why?
| | Survival Analysis | 2 | 2008 | 1382 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 372 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 202 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2016 | 579 | 0.020 |
Why?
| | Plasmodium | 1 | 2011 | 13 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 521 | 0.020 |
Why?
| | NF-kappa B | 2 | 2006 | 661 | 0.020 |
Why?
| | Rodentia | 1 | 2011 | 61 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1313 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2003 | 905 | 0.020 |
Why?
| | Flagella | 1 | 2010 | 27 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 744 | 0.020 |
Why?
| | Mitochondria | 1 | 2017 | 984 | 0.020 |
Why?
| | Transcription Factors | 2 | 2012 | 1741 | 0.020 |
Why?
| | Cell Division | 2 | 2003 | 766 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2012 | 496 | 0.020 |
Why?
| | Parasitemia | 1 | 2008 | 15 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2010 | 402 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2008 | 64 | 0.020 |
Why?
| | RNA | 1 | 1995 | 940 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 276 | 0.020 |
Why?
| | Corpus Luteum | 1 | 2007 | 20 | 0.020 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2007 | 22 | 0.020 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 361 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 380 | 0.020 |
Why?
| | Transcription Factor TFIID | 1 | 2007 | 21 | 0.020 |
Why?
| | Cachexia | 1 | 2008 | 75 | 0.020 |
Why?
| | Leptin | 1 | 2008 | 245 | 0.020 |
Why?
| | Disease Progression | 2 | 2008 | 2847 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2006 | 15 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2006 | 27 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2006 | 27 | 0.020 |
Why?
| | Protein Phosphatase 1 | 1 | 2006 | 32 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2006 | 5 | 0.020 |
Why?
| | Eating | 1 | 2008 | 389 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 266 | 0.010 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 173 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 758 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 2006 | 180 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2006 | 766 | 0.010 |
Why?
| | Centrosome | 1 | 2004 | 71 | 0.010 |
Why?
| | Protein Kinases | 1 | 2006 | 315 | 0.010 |
Why?
| | Cell Polarity | 1 | 2004 | 137 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2007 | 737 | 0.010 |
Why?
| | Estrogens | 1 | 2006 | 380 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 455 | 0.010 |
Why?
| | Transcription Initiation Site | 1 | 2003 | 43 | 0.010 |
Why?
| | Transcription Factor AP-2 | 1 | 2003 | 82 | 0.010 |
Why?
| | Hypertrophy | 1 | 2003 | 127 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3409 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2008 | 935 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2006 | 529 | 0.010 |
Why?
| | Insulin | 1 | 2013 | 2507 | 0.010 |
Why?
| | Point Mutation | 1 | 2003 | 243 | 0.010 |
Why?
| | Progesterone | 1 | 2003 | 255 | 0.010 |
Why?
| | Enzymes | 1 | 2001 | 65 | 0.010 |
Why?
| | Multigene Family | 1 | 2001 | 204 | 0.010 |
Why?
| | Transfection | 1 | 2003 | 940 | 0.010 |
Why?
| | Stomach Diseases | 1 | 2000 | 20 | 0.010 |
Why?
| | Neoplasms | 1 | 1996 | 2875 | 0.010 |
Why?
| | Binding Sites | 1 | 2003 | 1329 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 824 | 0.010 |
Why?
| | Trigeminal Nerve | 1 | 1998 | 27 | 0.010 |
Why?
| | Heterozygote | 1 | 1998 | 315 | 0.010 |
Why?
| | Liver Diseases | 1 | 2000 | 304 | 0.010 |
Why?
| | Follicular Cyst | 1 | 1996 | 1 | 0.010 |
Why?
| | Axons | 1 | 1998 | 201 | 0.010 |
Why?
| | Activin Receptors | 1 | 1995 | 3 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1499 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1998 | 675 | 0.010 |
Why?
| | Palate | 1 | 1995 | 39 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 72 | 0.010 |
Why?
| | Skull | 1 | 1995 | 158 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 1995 | 479 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1997 | 2527 | 0.010 |
Why?
| | Middle Aged | 1 | 2013 | 35875 | 0.010 |
Why?
| | Biomarkers | 1 | 2001 | 4271 | 0.000 |
Why?
| | Adult | 1 | 2013 | 40449 | 0.000 |
Why?
| | Neurons | 1 | 1998 | 1640 | 0.000 |
Why?
|
|
Kumar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|